| TOP | 
         
          | Ozex Tablets 100¡Á75mg£¨Tosufloxacin Í×ÊæÉ³ÐÇÆ¬£© 
               
                | 
  
  
    |  |  |  |  
    |  | Ò©µê¹ú±ð£º |  |  
      | ²úµØ¹ú¼Ò£º | ÈÕ±¾ |  
        | ´¦ ·½ Ò©£º | ÊÇ |  
          | ËùÊôÀà±ð£º | 75ºÁ¿Ë/Ƭ 100/Ƭ/ºÐ |  
            | °ü×°¹æ¸ñ£º | 75ºÁ¿Ë/Ƭ 100/Ƭ/ºÐ |  
              | ¼Æ¼Ûµ¥Î»£º | ºÐ |  
            | 
              
                | Éú²ú³§¼ÒÖÐÎIJο¼ÒëÃû: |  
                | ¸»Ê¿¸»É½»¯Ñ§ÓÐÏÞ¹«Ë¾ |  
                | Éú²ú³§¼ÒÓ¢ÎÄÃû: |  
                | FUJIFILM Toyama Chemical Co.Ltd. |  
                | ¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·1: |  
                | https://www.drugfuture.com/chemdata/tosufloxacin.html |  
                | ¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·2: |  
                |  |  
                | ¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·3: |  
                |  |  | 
              
                | Ô²úµØÓ¢ÎÄÉÌÆ·Ãû: |  
                | Ozex£¨¥ª¥¼¥Ã¥¯¥¹åV£©75mg/Tablets 100Tablets/box |  
                | Ô²úµØÓ¢ÎÄÒ©Æ·Ãû: |  
                | Tosufloxacin Tosilate Hydrate |  
                | ÖÐÎIJο¼ÉÌÆ·ÒëÃû: |  
                | Í×ÊæÉ³ÐÇ£¨¥ª¥¼¥Ã¥¯¥¹åV£©75ºÁ¿Ë/Ƭ 100/Ƭ/ºÐ |  
                | ÖÐÎIJο¼Ò©Æ·ÒëÃû: |  
                | ÍзúɳÐÇË®ºÏÎï |  
                | ÔøÓÃÃû: |  
                |  |  |  |  
               
                | 
                     
                      | ¼ò½é£º   ²¿·ÝÖÐÎÄÍ×ÊæÉ³ÐÇ´¦·½×ÊÁÏ£¨½ö¹©²Î¿¼£©Ó¢ÎÄÃû£ºTosufloxacin Tosilate Hydrate
 ÉÌÆ·Ãû£ºOzex Tablets
 ÖÐÎÄÃû£ºÍ×ÊæÉ³ÐÇ£¨ÍзúɳÐÇË®ºÏÎ
 Éú²úÉÌ£º¸»Ê¿¸»É½»¯Ñ§
 Ò©Æ·¼ò½é
 Ozex Tablets£¨Tosufloxacin Tosilate Hydrate£¬¥ª¥¼¥Ã¥¯¥¹åV£©ÊÇÒ»ÖÖÐÂàŵͪ¿Ú·þ¿¹¾úÖÆ¼Á¡£ÁÙ´²ÉϾßÓп¹¾úÆ×¹ã£¬¿¹¾ú×÷ÓÃÇ¿ÌØµã¡£¶Ô¸ïÀ¼ÑôÐÔ¾úµÄ×÷ÓÃÓÅÓÚ»·±û·úßßËá¡¢·úßßËáºÍ·úàºË᣻¶Ô¸ïÀ¼ÒõÐÔ¾úµÄ×÷ÓÃÓë»·±û·úßßËáÏàËÆ¶ÔÑáÑõ¾úÒ²ÓÐЧ£¬ÁÙ´²Ö÷ÒªÓÃÓÚºôÎüϵͳ¡¢³¦µÀ¡¢ÃÚÄòϵͳ¡¢Íâ¿Æ¡¢¸¾²ú¿Æ¡¢Æ¤·ôÈí×éÖ¯¡¢¼°Îå¹Ù¿ÆµÈ¸ÐȾ¡£
 ¥ª¥¼¥Ã¥¯¥¹åV75£¯¥ª¥¼¥Ã¥¯¥¹åV150
 ҩЧ·ÖÀàÃû³Æ
 ÐÂàŵͪ¿Ú·þ¿¹¾úÖÆ¼Á
 Åú×¼ÈÕÆÚ£º1990Äê 4ÔÂ
 É̘ËÃû
 OZEX Tablets
 Ò»°ãµÄÃû³Æ
 ¥È¥¹¥Õ¥í¥¥µ¥·¥ó¥È¥·¥ëËá‰cË®ºÍÎï
 £¨Tosufloxacin Tosilate Hydrate£©
 »¯Ñ§Ãû
 7-[(3RS)-3-Aminopyrrolidin-1-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid mono-4-toluenesulfonate monohydrate
 ·Ö×Óʽ
 C19H15F3N4O3・C7H8O3S・H2O
 ·Ö×ÓÁ¿
 594.56
 ÐÔ×´
 ËüÊǰ×É«ÖÁ΢»ÆÉ«µÄ°×É«½á¾§ÐÔ·ÛÄ©¡£Ëü¿É×ÔÓÉÈÜÓÚN£¬N-¶þ¼×»ù¼×õ£°·£¬Î¢ÈÜÓÚ¼×´¼£¬¼¸ºõ²»ÈÜÓÚË®»òÒÒ´¼£¨99.5£©¡£
 ¼×´¼ÈÜÒº£¨1→100£©Ã»ÓÐ×ªÒÆ¡£
 »¯Ñ§˜‹Ôìʽ
 ÈÛµã
 Ô¼254°C£¨·Ö½â£©
 Ëõд
 ÌØ·úɳÐÇ
 ҩЧҩÀí
 ×÷ÓûúÀí
 ËüÒÖÖÆÏ¸¾úDNAÍÓÂݺÍÍØÆËÒ칹øIV£¬²¢¾ßÓÐɱ¾ú×÷Óá£
 ¿¹¾ú×÷ÓÃ
 ÍзúɳÐǶԸïÀ¼ÊÏÑôÐԺ͸ïÀ¼ÊÏÒõÐÔϸ¾ú¾ßÓй㷺µÄ¿¹¾úÆ×£¬Æä×÷ÓÃÊÇɱ¾ú¡£
 Ëü¶ÔÆÏÌÑÌÇ£¬Lensa£¬·ÎÑ×£¨°üÀ¨ÄÍÇàÃ¹ËØµÄ·ÎÑ×£©£¬´ó³¦°£Ï£¾ú£¬¿ËÀײ®Êϸ˾ú£¬Á÷¸Ð£¬»¯Å§ÐÔºÍÄâ¸Ë¾úÊô¾ßÓм«ºÃµÄ¿¹¾ú»îÐÔ¡£Ëü»¹ÏÔʾ³ö¶ÔÒÂÔÌåɳÑÛÒÂÔÌ壨ɳÑÛÒÂÔÌ壩£¬É˺®Ï¸¾úºÍ¸±É˺®Ï¸¾úµÄÓÅÒ쿹¾ú»îÐÔ¡£»ôÂÒµÄMIC50ºÍMIC90·Ö±ðΪ≤0.006μg/ mLºÍ0.05μg/mL¡£»îÐÔÌ¿µÄMICΪ0.012μg/mL£¨½ÓÖÖ106¸öϸ°û/mLʱ£©¡£
 ×¢£©¸ù¾ÝCLSI£¨ÁÙ´²ºÍʵÑéÊÒ±ê׼лᣩµÄ±ê×¼£¬µ±ÇàÃ¹ËØµÄMIC£¨¿Ú·þÇàÃ¹ËØV£©µÄMIC´óÓÚ»òµÈÓÚ2μg/mLʱ£¬±»Åж¨ÎªÄÍÇàÃ¹ËØÐÔ·ÎÑס£
 ¶ÔʵÑéÐÔ¸ÐȾµÄÖÎÁÆ×÷ÓÃ
 ËüÏÔʾÁËÒ»ÖÖÖÎÁÆÐ§¹û£¬¸ÃЧ¹û·´Ó³ÁËÔÚʵÑéÖÆ±¸µÄСÊóÃâÒßÒÖÖÆÆÚ¼ä¶ÔÈ«Éí¸ÐȾ£¬Æ¤ÏÂŧÖ×£¬¼¹ËèÑ×£¬·ÎÑ×£¬Äò·¸ÐȾºÍÈ«Éí¸ÐȾµÄ¿¹¾ú»îÐÔ¡£
 ´ËÍ⣬ÔÚ³¦Ñ×ɳÃÅÊϾú¸ÐȾÈËÌ¥·Î³ÉÏËάϸ°ûµÄϸ°ûÄÚ¸ÐȾʵÑéÖУ¬Ï¸°ûÄÚÒÆÎ»ºÍϸ°ûÄÚɱ¾ú»îÐÔÓÅÓÚ·úɳÐǺÍŵ·úɳÐÇ¡£
 µÖ¿¹ÐÔ
 ʹÓûÆÉ«ÆÏÌÑÇò¾ú£¬´ó³¦¸Ë¾ú£¬É³À×ÊϾúºÍÂÌɫŧҺ¼ì²éÌìÈ»¿¹ÐÔϸ¾úµÄ·¢ÉúƵÂʵĽá¹ûÊÇ£¬¸ÃƵÂʽϵͣ¬²¢ÇÒͨ¹ý´àÈõÄâ¸Ë¾úµÄÔöÇ¿´«´ú·½·¨»ñµÃµÄ¿¹ÐԽϵͣ¬MICÉý¸ß¡£Ö±µ½µÚ8´ú²Å±»ÈϿɡ£
 ÊÊÓ¦Ö¢
 ・ ÊÊÓ¦¾ú·N
 ÍзúɳÐÇÃô¸ÐµÄÆÏÌÑÇò¾ú£¬¾§×´Ì壬·ÎÑ×£¨°üÀ¨ÄÍÇàÃ¹ËØµÄ·ÎÑ×£©£¬³¦Çò¾ú£¬gonococcus£¬moluxera£¨branhamera£©catalaris£¬Ä¾Ì¿£¬´ó³¦¸Ë¾ú£¬¸¹Ðº£¬É³ÃÅÊϾú£¬É˺®£¬ Palatifus£¬ÄûÃÊËá¸Ë¾ú£¬Krebsiera£¬Enterobactor£¬Seratia£¬Proteus£¬Morganella Morgany£¬Providencecia£¬»ôÂÒ£¬Á÷ÐÐÐÔ¸Ð𣬻¯Å§£¬Burkholderia Sepasia£¬Stenotrohomonas£¨Zantomonas£© ÊÈÂóÑ¿æß¸Ë¾ú£¬²»¶¯¸Ë¾ú£¬ëÄÁ´Çò¾ú£¬Äâ¸Ë¾ú£¬Prebotera£¬ðî´¯£¬ÒÂÔÌåÒÂÔÌ壨ɳÑÛÒÂÔÌ壩¡£
 ・ ÊÊÓ¦Ö¢
 dz±íƤ·ô¸ÐȾ£¬Éî²ãƤ·ô¸ÐȾ£¬Áܰ͹Ü/ÁܰͽáÑ×£¬ÂýÐÔŧƤ²¡£¬ðî´¯£¨Óл¯Å§ÐÔÑ×Ö¢£©£¬¼Ì·¢ÐÔ¸ÐȾ£¬ÀýÈçÍâÉË/ÉÕÉ˺ÍÊÖÊõÉ˿ڣ¬ÈéÏÙ Ñ×Ö¢£¬¸ØÖÜŧÖ×£¬¼¹ËèÑ×£¬¹Ø½ÚÑ×£¬ÑÊ/ºíÑ×£¬±âÌÒÌåÑ×£¨°üÀ¨¸¹Ä¤Å§Ö×£©£¬¼±ÐÔÖ§Æø¹ÜÑ×£¬·ÎÑ×£¬ÂýÐÔºôÎüµÀ²¡±äµÄ¼Ì·¢¸ÐȾ£¬°òë×Ñ×£¬ÉöÑ×£¬Ç°ÁÐÏÙÑ×£¨ ¼±ÐÔ¼²²¡£¬ÂýÐÔ¼²²¡£©£¬Ëø¹ÇÉÏÑ×£¨ÉöÑ×£©£¬ÃÚÄòµÀÑ×Ö¢£¬µ¨ÄÒÑ×£¬µ¨¹ÜÑ×£¬¸ÐȾÐÔ³¦Ñ×£¬³¦É˺®£¬ÅÁÀ¶¡£¬»ôÂÒ£¬°Í¶ûÌØÁÖÏÙÑ×£¬×Ó¹¬ÄÚ¸ÐȾ£¬×Ó¹¬¸½¼þÑ×£¬ÑÛÀá ÑÛ´üÑ×£¬»Æ°ß²¿Ö×Áö£¬íúÏÙÏÙÑ×£¬Íâ¶úÑ×£¬ÖжúÑ×£¬±Çñ¼Ñ×£¬»¯Å§ÐÔÍÙÒºÏÙÑ×£¬ÑÀÖÜÑ×£¬¸ØÖÜÑ×£¬ò¢¹ÇÑ×£¬Ä¾Ì¿¡£
 Ó÷¨ÓëÓÃÁ¿
 ・ ³ýÁ˼¹ËèÑ×£¬¹Ø½ÚÑ×£¬³¦É˺®£¬¸±É˺®>
 ͨ³££¬¶ÔÓÚ³ÉÄêÈË£¬ÒÔ2µ½3¸ö·Ö´Î¼ÁÁ¿¿Ú·þ300ÖÁ450ºÁ¿ËµÄÍзúɳÐǼױ½»ÇËáÑÎË®ºÏÎ204ÖÁ306ºÁ¿ËµÄÍзúɳÐÇ£©¡£
 ・ ¼¹ËèÑ×£¬¹Ø½ÚÑ×>
 ³ÉÈËͨ³£µÄ¼ÁÁ¿ÊÇ·ÖÈý¼Á¿Ú·þ450ºÁ¿ËµÄÍзúɳÐǼױ½»ÇËáÑÎË®ºÏÎ306ºÁ¿ËµÄÍзúɳÐÇ£©¡£
 ・ ³¦É˺®£¬¸±É˺®
 ͨ³££¬¶ÔÓÚ³ÉÄêÈË£¬ÒÔ4´Î·Ö´Î¿Ú·þ¿Ú·þ600mgÍзúɳÐǼױ½»ÇËáÑÎË®ºÏÎ408mgÍзúɳÐÇ£©£¬³ÖÐø14Ìì¡£
 ÔÚ³¦É˺®ºÍ¸±É˺®ÒÔÍâµÄÇé¿öÏ£¬¿É¸ù¾Ý´«È¾²¡µÄÀàÐͺÍÖ¢×´µ÷Õû¼ÁÁ¿¡£¿Ú·þ¡£
 °ü×°
 Ƭ
 Ƭ¼Á
 75ºÁ¿Ë£º100Ƭ[10Ƭ£¨PTP£©x 10]
 150ºÁ¿Ë£º100Ƭ[10Ƭ£¨PTP£©x 10]¡¢300Ƭ[15Ƭ£¨PTP£©x 20]¡¢500Ƭ[10Ƭ£¨PTP£©x 50]
 900Ƭ[15Ƭ£¨PTP£©x 60]
 ÖÆÔìÉ̺ͷÖÏúÉÌ
 ¸»Ê¿¸»É½»¯Ñ§ÓÐÏÞ¹«Ë¾
 ×¢£ºÒÔÉÏÖÐÎÄ´¦·½×ÊÁϲ»¹»ÍêÕû£¬Ê¹ÓÃÕßÒÔÔ´¦·½×ÊÁÏΪ׼¡£
 ÍêÕû˵Ã÷×ÊÁϸ½¼þ£º
 https://www.info.pmda.go.jp/go/pack/6241010F1020_2_06/
 |  |   
                |  |   
                | ¡¾´ó ÖРС¡¿¡¾´òÓ¡¡¿ 
                  
                  ¡¾·±Ìå¡¿¡¾Í¶¸å¡¿¡¾Êղء¿ 
                  ¡¾ÍƼö¡¿¡¾¾Ù±¨¡¿¡¾ÆÀÂÛ¡¿ 
                  ¡¾¹Ø±Õ¡¿ ¡¾·µ»Ø¶¥²¿¡¿ |  
              |  |   
                | ÉÏһƪ£ºOzex Tablets 100¡Á150mg£¨Tosufl.. | ÏÂһƪ£ºCiproxan Tablets 100¡Á200mg£¨Ci.. |  |